iDAP Injection for Parkinson's Disease
Part of Brain & nervous system clinical trials.
This trial tests an injected medication called iDAP for people with moderate-stage Parkinson's disease. It aims to see if iDAP can improve movement symptoms when added to your current treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old.
- You have been diagnosed with Parkinson's disease for at least 4 years, but no more than 20 years.
- Your Parkinson's is at stage 2, 3, or 4 on the Hoehn and Yahr scale (meaning you have some balance or movement issues but are not bedridden).
- You have been on the same dose of dopamine medication (like levodopa) for at least 3 months.
- You have not had brain surgery or used stem cell treatments before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests whether injecting special cells into the brain can improve Parkinson's symptoms. It is for people who have had Parkinson's for at least 5 years, take levodopa but still have times when the medication wears off or causes uncontrolled movements.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial tests a new treatment made from special cells injected into the brain to help people with Parkinson's disease who take levodopa but still have complications like wearing off or involuntary movements.
This early-stage trial tests a new stem cell treatment called NCR201 for people with Parkinson's. It aims to see if the treatment is safe and might help improve symptoms.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.